Anticorps Recombinant de lapin anti-TWEAKR/CD266

TWEAKR/CD266 Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

souris

Applications

FC

Conjugaison

Non conjugué

CloneNo.

241646F11

N° de cat : 98382-2-RR

Synonymes

TNFRSF12, TWEAK R, CD266, FGF-inducible 14, Fgfrp2



Applications testées

Résultats positifs en cytométrieTransfected HEK-293T cells,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98382-2-RR cible TWEAKR/CD266 dans les applications de FC et montre une réactivité avec des échantillons souris

Réactivité souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène TWEAKR/CD266 Protéine recombinante Eg1838
Nom complet tumor necrosis factor receptor superfamily, member 12a
Masse moléculaire calculée14kDa
Numéro d’acquisition GenBankNM_013749.2
Symbole du gène Tnfrsf12a
Identification du gène (NCBI) 27279
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

TWEAKR (also known as CD266, FN14, TNFRSF12A) is a member of the TNF receptor superfamily which is activated by its ligand, the cytokine TWEAK (TNFSF12). TWEAKR is the smallest member of the TNFR superfamily. TweakR was first described as an FGF-inducible gene that played a role in fibroblast adhesion and migration. Subsequently, the induction of TweakR expression by other growth factors and/or upon tissue injury was observed in multiple cell types, including hepatocytes, endothelial cells, adipocytes, and cardiomyocytes. (PMID: 23073510, PMID: 24409185)

Protocole

Product Specific Protocols
FC protocol for TWEAKR/CD266 antibody 98382-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}